To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 15,240 shares, the number of shares held decreased 0.73% compared to the previous period and now represents 3.32% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 318 shares, the number of shares held decreased 0.71% compared to the previous period and now represents 1.18% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 1,692 shares, the number of shares held decreased 0.72% compared to the previous period and now represents 4.25% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 2,120 shares, the number of shares held increased 0.098% compared to the previous period and now represents 4.88% of the total position.
      25Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,470 shares, the number of shares held decreased 0.72% compared to the previous period and now represents 1.49% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 11,412 shares, the number of shares held decreased 0.73% compared to the previous period and now represents 2.17% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 288 shares, the number of shares held decreased 0.71% compared to the previous period and now represents 0.68% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 6,527 shares, the number of shares held decreased 0.38% compared to the previous period and now represents 8.64% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 4,782 shares, the number of shares held decreased 0.73% compared to the previous period and now represents 5.58% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 3,860 shares, the number of shares held increased 0.2% compared to the previous period and now represents 8.25% of the total position.
      8Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed